Clinical trial
Dendritic Cell Based Therapy of Renal Cell Carcinoma
NCT00197860 · Inge Marie Svane, Other · Completed
Key facts
| NCT number | NCT00197860 |
|---|---|
| Title | Dendritic Cell Based Therapy of Renal Cell Carcinoma |
| Official title | Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Renal Cell Carcinoma.A Phase I/II Study. |
| Lead sponsor | Inge Marie Svane, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Renal Cell Carcinoma |
| Intervention type | Biological |
| Interventions | tumor antigen loaded autologous dendritic cells |
| Enrollment | 40 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2009 |
| Completion | Oct 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 23, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: